Novo Nordisk
Novo Nordisk (NVO) is a global healthcare company headquartered in Denmark, specializing in the development, production, and marketing of pharmaceutical products and services. The company is a leader in diabetes care, offering a comprehensive portfolio of insulin and GLP-1 receptor agonists. In addition to diabetes care, Novo Nordisk has a robust presence in other therapeutic areas, including obesity care, hemophilia, growth hormone therapy, and hormone replacement therapy. The company is committed to advancing medical treatments and improving quality of life for patients worldwide.